Jesse Hall
JH
Jesse Hall
Chief Medical Officer
About
Jesse Hall, M.D., has served as Chief Medical Officer for Aclaris Therapeutics since April 2025. He brings decades of leadership experience in all phases of drug development, from early development through global regulatory filings and approvals, Phase IV post-marketing surveillance obligations, and commercial launch support. Dr. Hall has been involved in the development and successful launches of therapeutics including the monoclonal antibodies HUMIRA® (adalimumab) and PROLIA® (denosumab).
Frequently asked
Who is Jesse Hall?
Jesse Hall, M.D., has served as Chief Medical Officer for Aclaris Therapeutics since April 2025. He brings decades of leadership experience in all phases of drug development, from early development through global regulatory filings and approvals, Phase IV post-marketing surveillance obligations, and commercial launch support. Dr. Hall has been involved in the development and successful launches of…
What is Jesse Hall's current role?
Jesse Hall is currently Chief Medical Officer.
Comments
No comments yet. Be the first to share your take.
Profile
About Jesse Hall
Jesse Hall is Chief Medical Officer. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.